Evaluation of lipopolysaccharide-induced activation of equine neutrophils.
- Journal Article
Summary
The study examines how lipopolysaccharide (LPS), a bacterial endotoxin, affects the activation of neutrophils, a type of white blood cell, in horses.
Objective and Methodology
The main goal of the research was to evaluate how a bacterial endotoxin known as lipopolysaccharide (LPS) activated equine neutrophils, a type of white blood cell. These cells play a vital role in the horse’s immune response to bacterial infections. The study used blood samples from five healthy adult Thoroughbred horses. The neutrophils in those samples were observed for their integrin expression (a type of protein involved in adherence to other cells), variations in size, degranulation (the release of antimicrobial substances), and their deformability with and without the presence of LPS.
Furthermore, the study involved conducting time and concentration studies to better understand the mechanisms regarding LPS-induced neutrophil activation. The researchers also used various inhibitors to investigate the role of different factors, including tumor necrosis factor-alpha (TNF-alpha) synthesis, prostaglandin-leukotriene synthesis, or platelet-activating factor.
Results
- The incubation of equine neutrophils with LPS led to an increased cell surface expression of adhesion molecules (integrins, CD11/CD18).
- Neutrophil deformability (the ability of the cell to change its shape) decreased after being exposed to LPS.
- There was a fluctuation in the size of the neutrophils — they either increased or decreased.
- The endotoxin also triggered degranulation, which is the release of antimicrobial cytotoxic molecules contained within the neutrophils used to combat infections.
Conclusions
The research concluded that the process of equine neutrophils being activated readily by LPS could be observed in vitro. This activation brought about increased expression of integrin adhesion molecules, decreased deformability, size variation, and neutrophil degranulation. It was observed that this effect could be mitigated by inhibiting the TNF-alpha and prostaglandin-leukotriene synthesis.
In conclusion, the research suggests the potential use of these tests for detecting activated neutrophils in vivo in horses with conditions such as sepsis and endotoxemia, providing a helpful diagnostic tool in equine medicine.
Cite This Article
Publication
Researcher Affiliations
- Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St Paul 55108, USA.
MeSH Terms
- 5,8,11,14-Eicosatetraynoic Acid / pharmacology
- Animals
- Azepines / pharmacology
- CD11 Antigens / biosynthesis
- CD18 Antigens / biosynthesis
- Cell Degranulation / immunology
- Complement System Proteins / immunology
- Cyclooxygenase Inhibitors / pharmacology
- Enzyme Inhibitors / pharmacology
- Flow Cytometry / veterinary
- Horses / blood
- Horses / immunology
- Interleukin-8 / antagonists & inhibitors
- Interleukin-8 / immunology
- Lipopolysaccharides / immunology
- Lipopolysaccharides / pharmacology
- Neutrophil Activation / drug effects
- Neutrophil Activation / immunology
- Neutrophils / drug effects
- Neutrophils / immunology
- Neutrophils / pathology
- Pentoxifylline / pharmacology
- Platelet Activating Factor / antagonists & inhibitors
- Platelet Activating Factor / immunology
- Platelet Aggregation Inhibitors / pharmacology
- Triazoles / pharmacology
- Tumor Necrosis Factor-alpha / antagonists & inhibitors
- Tumor Necrosis Factor-alpha / immunology
Citations
This article has been cited 5 times.- Anderson MJ, Ibrahim AS, Cooper BR, Woolcock AD, Moore GE, Taylor SD. Effects of administration of ascorbic acid and low-dose hydrocortisone after infusion of sublethal doses of lipopolysaccharide to horses. J Vet Intern Med 2020 Nov;34(6):2710-2718.
- Fingerhut L, Dolz G, de Buhr N. What Is the Evolutionary Fingerprint in Neutrophil Granulocytes?. Int J Mol Sci 2020 Jun 25;21(12).
- Sheats MK. A Comparative Review of Equine SIRS, Sepsis, and Neutrophils. Front Vet Sci 2019;6:69.
- Zhang M, Xu YJ, Mengi SA, Arneja AS, Dhalla NS. Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol 2004 Summer;9(2):103-11.
- Urayama S, Muko R, Muranaka M, Mita H, Ohta M, Matsuda H, Tanaka A. Differential effects of flunixin meglumine and meloxicam on TNF- α production in LPS-stimulated equine neutrophils in vitro. Vet Anim Sci 2025 Dec;30:100513.